Ad is loading...
ACLX
Price
$84.46
Change
-$1.96 (-2.27%)
Updated
Dec 6, 04:59 PM (EDT)
101 days until earnings call
RCUS
Price
$17.32
Change
+$0.21 (+1.23%)
Updated
Dec 6, 04:59 PM (EDT)
73 days until earnings call
Ad is loading...

ACLX vs RCUS

Header iconACLX vs RCUS Comparison
Open Charts ACLX vs RCUSBanner chart's image
Arcellx
Price$84.46
Change-$1.96 (-2.27%)
Volume$6K
CapitalizationN/A
Arcus Biosciences
Price$17.32
Change+$0.21 (+1.23%)
Volume$8.91K
CapitalizationN/A
ACLX vs RCUS Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACLX vs. RCUS commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a StrongSell and RCUS is a Buy.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (ACLX: $84.55 vs. RCUS: $17.29)
Brand notoriety: ACLX and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 56% vs. RCUS: 79%
Market capitalization -- ACLX: $4.67B vs. RCUS: $1.57B
ACLX [@Biotechnology] is valued at $4.67B. RCUS’s [@Biotechnology] market capitalization is $1.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 6 bearish.
  • RCUS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -4.00% price change this week, while RCUS (@Biotechnology) price change was +11.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

RCUS is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.67B) has a higher market cap than RCUS($1.57B). ACLX YTD gains are higher at: 52.342 vs. RCUS (-9.476). ACLX has higher annual earnings (EBITDA): -33.12M vs. RCUS (-257M). RCUS has more cash in the bank: 1.09B vs. ACLX (574M). RCUS has less debt than ACLX: RCUS (58M) vs ACLX (65.3M). RCUS has higher revenues than ACLX: RCUS (263M) vs ACLX (156M).
ACLXRCUSACLX / RCUS
Capitalization4.67B1.57B298%
EBITDA-33.12M-257M13%
Gain YTD52.342-9.476-552%
P/E RatioN/AN/A-
Revenue156M263M59%
Total Cash574M1.09B53%
Total Debt65.3M58M113%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXRCUS
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 28 days ago
89%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 21 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BKAG42.300.10
+0.24%
BNY Mellon Core Bond ETF
OWNS17.390.04
+0.23%
CCM Affordable Housing MBS ETF
XTR34.02N/A
N/A
Global X S&P 500® Tail Risk ETF
AIVL112.22-0.26
-0.23%
WisdomTree US Al Enhanced Val ETF
XOMO15.55-0.15
-0.97%
YieldMax XOM Option Income Strategy ETF

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-2.16%
BEAM - ACLX
50%
Loosely correlated
+5.49%
CRSP - ACLX
48%
Loosely correlated
+5.70%
RCKT - ACLX
48%
Loosely correlated
+4.28%
DNLI - ACLX
47%
Loosely correlated
+6.73%
INZY - ACLX
46%
Loosely correlated
+3.63%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with OCUL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+1.05%
OCUL - RCUS
45%
Loosely correlated
+4.79%
DNLI - RCUS
45%
Loosely correlated
+6.73%
ACLX - RCUS
45%
Loosely correlated
-2.16%
ALLO - RCUS
44%
Loosely correlated
+2.34%
PRME - RCUS
43%
Loosely correlated
+10.10%
More